Assessing Diazinon Exposure: A GC-MS/MS Validation Study of BChE Measurement by Point-of-Care Testing and Enzyme Multiplied Immunoassay Technique
Molecules · 2025
DOI: 10.3390/molecules30112382 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Molecules, 2025. Verfasst von Andreea-Camelia Hîrjău und 3 weiteren Autor:innen. Beteiligte Einrichtung: "Cantacuzino" National Institute for Medical-Military Research and Development, 050096 Bucharest, Romania. Hauptthemen laut MEDLINE: Diazinon, Butyrylcholinesterase, Point-of-Care Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of National Defense, Romanian Ministry of National Defence.
Abstract (Originalsprache)
This study addresses the challenge of accurately assessing diazinon exposure in suspected self-poisoning cases. We evaluated butyrylcholinesterase (BChE) levels using a point-of-care (POCT) whole blood assay (adapted Ellman method) and compared it with the standard plasma Enzyme Multiplied Immunoassay Technique (EMIT). Diazinon exposure in four patients was confirmed using a validated gas chromatography–tandem mass spectrometry (GC-MS/MS) method with multiple reaction monitoring (MRM). A strong positive correlation was observed between POCT and EMIT BChE activity (r = 0.9638, p < 0.0001), indicating general agreement in BChE trends. However, Bland–Altman analysis revealed discrepancies in absolute BChE values. Notably, admission diazinon concentrations (GC-MS/MS) were significantly negatively correlated with BChE activity measured by both POCT (r = −0.9333, p = 0.0205) and EMIT (r = −0.9302, p = 0.0219). The POCT assay offers rapid, preliminary BChE assessments in suspected diazinon intoxication, useful in emergency settings. However, due to observed discrepancies, confirmatory testing with EMIT or GC-MS/MS is recommended for accurate quantification. This research highlights the critical need for robust confirmatory methods, such as GC-MS/MS, to validate rapid assays and improve the accuracy of diazinon intoxication detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- "Cantacuzino" National Institute for Medical-Military Research and Development, 050096 Bucharest, Romania.
- Doctoral School of "Chemical Engineering and Biotechnologies", National University of Science and Technology Politehnica Bucharest, 011061 Bucharest, Romania.
- Department of Analytical Chemistry and Environmental Engineering, Faculty of Chemical Engineering and Biotechnologies, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.
ORCID-Profile: Andreea-Camelia Hîrjău, Gabriel-Lucian Radu
Förderung
- Romanian Ministry of National Defense
- Romanian Ministry of National Defence
Zitieren
APA
Hîrjău, A. C., Crăciun, M. E., Marandiuc, I. M., & Radu, G. L. (2025). Assessing Diazinon Exposure: A GC-MS/MS Validation Study of BChE Measurement by Point-of-Care Testing and Enzyme Multiplied Immunoassay Technique. Molecules. https://doi.org/10.3390/molecules30112382
Vancouver
Hîrjău AC, Crăciun ME, Marandiuc IM, Radu GL. Assessing Diazinon Exposure: A GC-MS/MS Validation Study of BChE Measurement by Point-of-Care Testing and Enzyme Multiplied Immunoassay Technique. Molecules. 2025. doi:10.3390/molecules30112382
BibTeX
@article{Hrju2025,
author = {Hîrjău, Andreea-Camelia and Crăciun, Mihaela Emanuela and Marandiuc, Ilinca-Mihaela and Radu, Gabriel-Lucian},
title = {Assessing Diazinon Exposure: A GC-MS/MS Validation Study of BChE Measurement by Point-of-Care Testing and Enzyme Multiplied Immunoassay Technique},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112382}
}
EUVIMED